Skip to main content
Caplight Logo









PharMolix

PharMolix

Private
BeijingHealthcare & Life Scienceshttps://pharmolix.com/zh

Last Round

Angel

Aug 14, 2024

Company Overview

PharMolix is a biotechnology company that develops AI-powered foundation models and conversational assistants for the biomedical and drug discovery industry.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, NLP & Conversational AI

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Foundation

Keywords

drug discoveryfoundation modelsprotein designmolecular modelingfrontier ai labbiomedical aiai drug discoverymolecular dockingmultimodal modelsbiotech aiprotein engineeringai research platformin silico drug designbiomedical signal analysisai model api

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PharMolix Comparables

Compare PharMolix with similar companies based on industry and business-model similarity.

PharMolix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EvolutionaryScale
81%
Genesis Molecular AI
76%
Cradle
74%

PharMolix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelAug 14, 2024
SeedAug 14, 2024

Key People

Founding team and executive leadership

Mu Qiao

Co-founder & Chief Technology Officer

Founding Team

Jerry Xing

COO

Executive Team

PharMolix Investors

Notable investors and investment history

PharMolix investors
InvestorRounds
Dalton VentureAngel
WestSummit CapitalAngel
讯飞创投Angel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 17, 2024

    Grew 150% QoQ from 2 to 5 employees.

  • Aug 14, 2024

    WestSummit Capital led the round.

PharMolix Filings

Explore SEC and related filing metadata, where available.

PharMolix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PharMolix's valuation, stock price, and market status.

Is PharMolix a public or private company?

PharMolix is a private company.

What is the current stock price of PharMolix?

PharMolix is a private company with no public stock price. Caplight tracks PharMolix's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is PharMolix worth (valuation)?

Valuation information for PharMolix is not publicly available.

Can I buy PharMolix stock?

PharMolix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PharMolix's last funding round?

PharMolix's most recent funding round was Seed on August 14, 2024.

Who are the main investors in PharMolix?

Key investors in PharMolix include WestSummit Capital.

Will PharMolix IPO soon?

No public IPO plans have been announced for PharMolix.

How can I track PharMolix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PharMolix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Employee Range6
Year Founded2023
Last FundingAug 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?